Magnetic resonance in clinical imaging and diagnosis provides diagnostic capabilities never previously enjoyed by the medical community. However, the quality of information obtained depends on the choice of instrument parameters. Before an MR examination can be designed, the operator must be aware of the consequences of the scanning parameter choices made, as they will determine the success or failure of the study.
INTRODUCTION
Magnetic resonance in clinical imaging and diagnosis provides diagnostic capabilities never previously enjoyed by the medical community. However, the quality of information obtained depends on the choice of instrument parameters. Before an MR examination can be designed, the operator must be aware of the consequences of the scanning parameter choices made, as they will determine the success or failure of the study. 1 The contrast agent gadolinium-diethylene triamine pentaacetic acid (Gd-DTPA) reduces T1 and T2 relaxation times and creates very complex changes in the MRI signal. 2 Although Gd-DTPA has been used as a contrast agent in MRI, it is known that the contrast enhancement effect disappears if the concentration of Gd-DTPA increases beyond some levels. [3] [4] [5] [6] Therefore, the determination of Gd-DTPA concentrations in vitro to provide optimal MRI signal intensity (SI) is vital to produce an image of the highest quality. On the other hand, it must be noted that the optimal pulse sequence will vary with field strength because of the frequency dependence of tissue T1 relaxation times. A number of models, which describe the influence of the magnetic field strength on both T1 and T2 relaxation times, predict a significant increase in T1 and a decrease in T2 when using higher magnetic field strengths. 4, 7 This decrease may result from the combination of susceptibility effects at elevated magnetic fields and diffusing of spins, resulting in a decreased value of T2.
To investigate further whether SI with a contrast agent in blood is similar to SI with the contrast agents in soft tissue, melanoma cells were incubated in different concentrations of Gd-DTPA before MRI. These results were validated by experiments using magnetic field strengths of 1.9 Tesla for measurements of longitudinal relaxation rates in melanotic melanoma. 8 The major goal of this work is to investigate the various MR parameters and their interdependence and to determine the optimal concentration of Gd-DTPA to enhance signal intensity
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for in vitro studies at a high magnetic field strength. To this end, 
MATERIALS AND METHODS
Magnetic resonance images were obtained on a 300 MHz, 
RESULTS

Signal intensity and concentration of Gd-DTPA solution
In 
Signal intensity and concentration of Gd-DTPA solutions in the presence of sodium chloride
The effect of a biological fluid, such as sodium chloride, on the signal intensity for a water phantom containing different concentrations of Gd-DTPA and 5 mol/L NaCl was investigated.
In vitro SI were measured by using transverse images of the samples. 
Signal intensity of blood samples with different Gd-DTPA concentrations
The signal enhancement properties of Gd-DTPA in blood samples were observed to rapidly increase non-linearly at a concentration of 1 mmol/L Gd-DTPA (Fig. 4) . Above this concentration, SI decreased with increased Gd-DTPA concentration. In the concentration range studied, for low concentrations A reference water phantom was included in the imaging plane to correct for system variation, which is up to 25% less than that for an aqueous solution of Gd-DTPA for a given concentration.
As Fig. 5 demonstrates, the enhancement ratio does not increase linearly with gadolinium concentration in melanoma.
In addition, T1 relaxation time measurements for aqueous solutions of Gd-DTPA (0.5 mmol/L) and melanoma cells with Gd-DTPA (0.5 mmol/L) were 1800 ms and 1100 ms, respectively. . The signal intensification at low concentrations of Gd-DTPA is due to T1 shortening; the loss of signal at higher Gd-DTPA concentrations is due to T2 shortening. Gd-DTPA is one of only a few contrast agents available clinically for MRI at present. 1 Application of Gd-DTPA has made dynamic MRI of several organs and tissues possible, especially in cancer tissue at low magnetic field strengths. [9] [10] [11] However, the contrast enhancement effect of Gd-DTPA varies according to the pulse sequences, 12 magnetic field strength 13 and Gd-DTPA concentration. 3 Paramagnetic contrast agents, such as Gd-DTPA, may cause field-dependent changes in the nuclear spin relaxation rates and the effects on the gadolinium concentration are linear.
Of course, the effect of data acquisition parameters, TE and TR in a spin-echo pulse sequence on the SI is given by the following equation:
where A is a constant. Both TR and TE are a linear function of gadolinium concentration. The correlation curve of SI and gadolinium concentration will be a function of TE and TR; that is, a shorter TR will move the turn-over seen to higher gadolinium concentrations as will a shorter TE.
In CT or scintigraphy, the concentration of contrast medium or radioisotope almost correlates linearly with the CT number or radioactivity, whereas the concentration of Gd-DTPA does not correlate with SI in MRI, 13 the reason being that Gd-DTPA has both T1 and T2 shortening effects. At low Gd-DTPA concentrations, the T1 shortening effect is dominant, and at high concentrations, the T2 shortening effect is dominant. 3, 6 In the latter condition, SI decreases with increasing Gd-DTPA concentration, as shown in this work. Signal plateaus at a high and sodium chloride at 4 mmol/L could be achieved by using T1-weighted MRI (Fig. 3) .The loss of SI at higher concentrations of Gd-DTPA is due to T2-shortening but the signal intensification at low concentrations of Gd-DTPA is due to T1-shortening.
These imaging data provide more detailed information about aqueous solutions of Gd-DTPA than had been reported previously by Takeda et al. and Brasch et al. 3, 16 R1 and R2 relaxivities for aqueous Gd-DTPA solutions is consistent with the literature and supports the theory that relaxivity is dependent on magnetic field strength. 1, 6 The relaxation times are indirect measures of the interactions that occur between water molecules and other cell constituents. 17 Water molecules in biological tissue can be classified into two types: free and bound. T1 relaxation values of tissues have been reported to vary with frequency and hence the applied magnetic field strength. 6 On the other hand, it must be noted that the optimal pulse sequence will vary with field strength because of the frequency dependence of tissue T1 relaxation times. A number of models that describe the influence of magnetic field strength on both T1 and T2 relaxation times predict a significant increase in T1 and a decrease in T2 when using higher magnetic field strengths. 1, 6 This result is consistent with the theory mentioned in the present article, which shows a higher T1 relaxation time for melanoma cells at 7.0 Tesla compared to a lower magnetic field strength reported previously. 8, 25 Magnetic resonance imaging has significant potential for the detection and evaluation of melanoma. . 26 In particular, Fe 3+ has been shown to bind to melanin excess paramagnetic and contribute significantly to the shortening of T1 relaxation times. 25 Generally, the contrast agent is effective in enhancing T1 and T2 relaxation rates. Water and blood were used to estimate the error caused from using incorrect calibration curves. The calibration curves generated by direct signal measurements of water with different Gd-DTPA concentrations (0-6 mmol/L) by using inversion recovery pulse sequence are y = 26.2x + 17.6
and y = 26.9x + 15.6. On the other hand, the calibration curves for blood and melanoma cells with different Gd-DTPA concentrations obtained using inversion recovery pulse sequence
show that a linear correlation does not exist between signal intensity and Gd-DTPA concentration.
CONCLUSIONS
In aqueous solutions of paramagnetic ions, a linear relationship between the paramagnetic ion concentration and relaxation rates is expected. 6 This relationship has been verified experimentally for aqueous Gd-DTPA solutions, Gd-DTPA solution in blood and in melanoma cells. These empirical data suggest that even in blood and soft tissues, T1 and T2 relaxation rates are proportional to the tissue gadolinium concentration. 3, 13 In addition, a number of models describing the influence of the magnetic field strength on both T1 and T2 relaxation times predicted a significant increase in T1 and a decrease in T2 when using higher magnetic field strengths. 4, 6 This decrease was possibly due to the concentration of susceptibility effects at elevated magnetic fields and diffusion of spins, resulting in a decreased value for T2. 5 The results of this work may help in the design of chemotherapeutic agents. The Gd-DTPA permeability study can provide information about tissue uptake of small chemotherapeutic agents for high resolution MR imaging studies.
The paramagnetic contribution to the relaxation rates makes quantitative studies of the uptake of paramagnetic contrast agents possible. These findings may also be useful for MRI of melanoma cells at 7.0 Tesla.
